0001784440 2026-01-01 2026-06-30 0001784440 2026-06-30 0001784440 2026-08-06 0001784440 2025-12-31 0001784440 2026-04-01 2026-06-30 0001784440 2025-04-01 2025-06-30 0001784440 2025-01-01 2025-06-30 0001784440 2024-12-31 0001784440 us-gaap:PreferredStockMember 2024-12-31 0001784440 us-gaap:CommonStockMember 2024-12-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001784440 us-gaap:RetainedEarningsMember 2024-12-31 0001784440 2025-01-01 2025-03-31 0001784440 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001784440 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001784440 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001784440 2025-03-31 0001784440 us-gaap:PreferredStockMember 2025-03-31 0001784440 us-gaap:CommonStockMember 2025-03-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001784440 us-gaap:RetainedEarningsMember 2025-03-31 0001784440 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001784440 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001784440 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001784440 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001784440 2025-06-30 0001784440 us-gaap:PreferredStockMember 2025-06-30 0001784440 us-gaap:CommonStockMember 2025-06-30 0001784440 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001784440 us-gaap:RetainedEarningsMember 2025-06-30 0001784440 us-gaap:PreferredStockMember 2025-12-31 0001784440 us-gaap:CommonStockMember 2025-12-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001784440 us-gaap:RetainedEarningsMember 2025-12-31 0001784440 2026-01-01 2026-03-31 0001784440 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001784440 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001784440 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001784440 2026-03-31 0001784440 us-gaap:PreferredStockMember 2026-03-31 0001784440 us-gaap:CommonStockMember 2026-03-31 0001784440 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001784440 us-gaap:RetainedEarningsMember 2026-03-31 0001784440 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001784440 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001784440 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001784440 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001784440 us-gaap:PreferredStockMember 2026-06-30 0001784440 us-gaap:CommonStockMember 2026-06-30 0001784440 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001784440 us-gaap:RetainedEarningsMember 2026-06-30 0001784440 2025-01-01 2025-12-31 0001784440 2025-12-01 2025-12-01 0001784440 us-gaap:FairValueInputsLevel1Member 2026-06-30 0001784440 fil:RelatedParty1Member 2025-06-30 0001784440 fil:RelatedParty1Member 2025-01-01 2025-06-30 0001784440 fil:RelatedParty1Member 2026-06-30 0001784440 fil:RelatedParty1Member 2026-01-01 2026-06-30 0001784440 fil:RelatedParty1Member 2026-01-01 2026-03-31 0001784440 fil:RelatedParty1Member 2026-03-31 0001784440 2025-09-09 0001784440 2025-09-10 2025-09-10 0001784440 2025-09-10 0001784440 us-gaap:PreferredStockMember 2021-10-19 0001784440 us-gaap:SeriesAPreferredStockMember 2021-11-01 0001784440 us-gaap:SeriesAPreferredStockMember 2021-11-01 2021-11-01 0001784440 us-gaap:SeriesAPreferredStockMember 2026-06-30 0001784440 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001784440 fil:UsdtMember 2026-06-30 iso4217:USD shares iso4217:USD shares pure 0001784440 --12-31 false true 2026 Q2 10-Q true 2026-06-30 false 333-234487 BIOSCIENCE HEALTH INNOVATIONS INC. NV 98-1498782 14857 South Concord Park Drive Bluffdale UT 84065 801 949-0791 None Yes Yes Non-accelerated Filer true true true false 11752329

712378

661925

396899

399257

34992

4500 0

797183

336348

40961

21341

137718

2069

1986913

1558658

109845

82887

4400

34992

61236

149237

148523

2136150

1707181

9715

6274

28542

7957

79030

2550

136590

260402

301209

229851

1000000

140000

0.0001

250000000

11752329

10979058

1176

1098

1948404

1175211

-114653

301007

1834941

1477330

2136150

1707181

1036364

1757463

1787310

2984533

376881

682985

642231

1013910

659483

1074478

1145079

1970623

804136

540074

1429945

973635

73229

76700

162923

112486

877365

616774

1592868

1086121

-217882

457704

-447789

884502

-32129

-185753

457704

-415660

884502

-0.02

0.04

-0.04

0.08

-0.02

0.04

-0.04

0.08

11684349

10979058

11353205

10979058

11684349

11399058

11353205

11399058

140000

10979058

1098

1175211

-341083

835240

426798

140000

10979058

1098

1175211

85715

1262038

457704

140000

10979058

1098

1175211

543419

1719742

140000

10979058

1098

1175211

301007

1477330

0 0 437067 44 437023 0 437067

-229907

140000

11416125

1142

1612234

71100

1684490

0 0 336204 34 336170 0 336204

-185753

140000

11752329

1176

1948404

-114653

1834941

-415660

884502

26244 0 4 0

-2358

289728

34992

456820

190200

-8519

-134041

224330

20585

18507

3441

8410

-79030

-2069

19620

42502

-1093981

613319

26958

46064

-26958

-46064

748120

1391635

150000

1322000

200000 0

773272

1171392

69635

50453

636890

661925

662517

712378

1299407

460402 0 4015 0

Note 1 - Nature of Organization Nowtransit Inc. (the “Company,” “us,” “we,” “Nowtransit”) was incorporated in the State of Nevada on July 8, 2019, and changed its name to BioScience Health Innovations Inc on February 21, 2025. Through March 10, 2023 we had no operations and had not generated any material revenues since inception. Effective March 10, 2023, we closed on a Share Exchange Agreement with Best 365 Labs Inc. (“Best”), a Nevada corporation, wherein we acquired all of the shares of Best and Best became a wholly owned subsidiary of the Company. Best was incorporated on October 12, 2021 in the State of Nevada. Best sells clinically-tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and in various other distribution channels in the health and wellness market.

Note 2 - Liquidity The condensed consolidated financial statements have been prepared in accordance with US generally accepted accounting principles, which assumes that the Company’s management will evaluate whether it will be able to meet its obligations and continue its operations in the normal course of business. The Company had net income of $642,090 and positive cash provided by operating activities of $172,178 for the year ended December 31, 2025. While the Company had a net loss of $415,660 during the six months ended June 30, 2026, they recorded accumulated deficit of $114,653, had net working capital of $1,685,704, and reported cash of $712,378 as of June 30, 2026, which management believes is sufficient to meet its obligations over the next year. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company determine it shall be unable to continue as a going concern.

642090

172178

-415660

-114653

-1685704

712378

Note 3 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) and with the rules and regulations of the Securities and Exchange Commission, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with US GAAP, have been condensed or omitted from these statements and should be read in conjunction with our audited financial statements. The financial statements are presented in US dollars, and the Company has adopted a December 31 year end. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses. Actual results could differ from those estimates. Segment Reporting The Company operates as a single operating and reportable segment as a retailer selling mental health and general wellness products. Our Chief Executive Officer, who serves as our Chief Operating Decision Maker (“CODM”), evaluates the Company’s financial performance and makes resource allocation decisions considering our one geographical area and on a consolidated basis. Accordingly, the CODM considers the revenue, operating expenses, and other income (expenses) of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these condensed consolidated financial statements that are regularly provided to the CODM. Cash and Cash Equivalents Cash and cash equivalents include cash on hand, cash in banks and any highly liquid investments with a maturity of three months or less to the extent the funds are not being held for investment purposes. As of June 30, 2026 and December 31, 2025, the Company had no cash equivalents. The Company maintains four accounts at Wells Fargo Bank. Accounts at this institution are insured by the Federal Deposit Insurance Corporation up to $250,000. As of June 30, 2026 the Company has balances of $250,153 more than this limit. Accounts Receivable and Allowance for Doubtful Accounts The Company reviews accounts receivable periodically for collectability and establishes an allowance for doubtful accounts and records bad debt expense when deemed necessary. The Company records an allowance for doubtful accounts that is based on historical trends, customer knowledge, any known disputes, and considers the aging of the accounts receivable balances combined with management’s estimate of future potential recoverability. Accounts and receivables are written off against the allowance after all attempts to collect a receivable have failed. As of June 30, 2026 and December 31, 2025, the allowance for doubtful accounts was $0. Inventory The Company’s inventory is recognized in accordance with Accounting Standards Codification (“ASC”) 303. The Company uses the lower of cost (determined using the first-in, first-out method) or net realizable value for valuing inventories. As of June 30, 2026 and December 31, 2025, the Company had $333,779 and $336,348 of finished goods on hand, respectively. And on June 30, 2026 and December 31, 2025, the Company had $463,405 and $0 of raw materials on hand respectively. Income Taxes The provision for income taxes and deferred income taxes are determined using the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the financial carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. On a periodic basis, the Company assesses the probability that its net deferred tax assets, if any, will be recovered. If after evaluating all of the positive and negative evidence, a conclusion is made that it is more likely than not that some portion or all of the net deferred tax assets will not be recovered, a valuation allowance is provided by a charge to tax expense to reserve the portion of the deferred tax assets which are not expected to be realized. Revenue Recognition The Company’s revenue is recognized in accordance with Accounting Standards Codification 606 and the Company sells products in the immune health supplement market. The Company’s performance obligation is to deliver product to customers therefore revenue is recognized once delivery occurs. Customers that are end users of the Company’s products will generally remit payment at the time of order placement, therefore payment received by the Company prior to product delivery is recorded as deferred revenue. Customers that are resellers of the Company’s products are offered credit terms and generally pay within 30-60 days. As of June 30, 2026 and December 31, 2025 deferred revenue was $2,550 and $136,590, respectively. Shipping and handling costs that occur are paid by the customer and is not recorded as revenue. The Company has a policy to provide a refund on any product returned by the customer and refunds are recorded as a reduction in revenue. Refunds have been minimal to date. Advertising Costs Advertising costs are expensed as incurred. During the six months ended June 30, 2026 and 2025, the Company incurred advertising costs of $298,503 and $159,743, respectively. Research and Development The Company charges research and development costs to expense when incurred. During the six months ended June 30, 2026 and 2025, the Company incurred $120,306 and $46,783 in research and development expenses, respectively. Intangible Assets The Company accounts for its intangible assets in accordance with ASC 350. Costs incurred to renew or extend the term of intangible assets are expensed as incurred. As of June 30, 2026, the Company incurred $109,845 to file certain patent applications that showcase the Company’s innovative approach to health and wellness solutions. The patent costs were capitalized and will be amortized on a straight-line basis over its estimated useful life once the patents are granted. During the six months ended June 30, 2026 and June 30, 2025 no amortization expense was recorded as the patents were still pending. Amortization expense of $5,492 is expected for each year ended December 31, 2027 and beyond. We have several patent applications pending in the U.S. and internationally for our innovative methylithioninium (methylene blue) and mitochondrial health compositions: Patent Pending Product Overview and Update U.S. Non-Provisional Patent Application No. 18/931,277 for METHYLTHIONINIUM SALT-CONTAINING COMPOSITIONS AND METHODS, filed on 10/30/2024 International Patent Application No. PCT/US24/53487 for METHYLTHIONINIUM SALT-CONTAINING COMPOSITIONS AND METHODS, filed on 10/30/2024 U.S. Non-Provisional Patent Application No. 18/931,346 for COMPOSITIONS AND METHOD FOR SUPPORTING MITOCHONDRIAL, file on 10/30/2024 International Patent Application No. PCT/US24/53490 for COMPOSITIONS AND METHOD FOR SUPPORTING MITOCHONDRIAL, file on 10/30/2024. Filed on 10/30/2024 U.S. Provisional Patent Application No. 19/371,824 for TREATMENTS USING METHYLTHIONINIUM SALT, LIQUID MINERAL BLENDS, and/or SECONDARY PHYSIOLOGICALLY ACTIVE COMPOUND AND PHYSIOLOGICAL THERAPY, filed on 10/28/2025 U.S. Provisional Patent Application No. 63/712,895 for TREATMENTS USING METHYLTHIONINIUM SALT, SECONDARY PHYSIOLOGICALLY ACTIVE COMPOUND AND PHYSIOLOGICAL THERAPY, filed on 10/28/2024 U.S. Provisional Patent Application No. 63/754,434 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 2/5/2025 U.S. Provisional Patent Application No. 19/173,875 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 4/9/2025 International Patent Application No. PCT/US26/13809 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 2/4/2026 U.S. Provisional Patent Application No. 64/025,742 for AQUEOUS PEPTIDE DELIVERY COMPOSITIONS AND METHODS, filed on 4/2/2026 All provisional applications were filed with the U.S. Patent and Trademark Office by Thorpe North and Western. We believe these filings cover multiple potential patents and product opportunities. Leadership is actively exploring partnerships and strategic alliances to maximize value for stakeholders. All products and methods described remain patent pending as of the date of this filing. Impairment of Long-lived Assets The Company applies the provisions of ASC 360, where applicable, to all long-lived assets and periodically evaluates the carrying value of long-lived assets to be held and used for impairment. Impairment losses are recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal. When long-lived assets are sold or retired, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations. During the six months ended June 30, 2026 and 2025, the Company recorded no impairment expense for their long-lived assets. Digital Assets Held for Operational Purposes The Company holds certain digital assets (primarily USDT) exclusively as a medium of exchange to facilitate inventory procurement from international vendors. Digital assets held for operational purposes are classified as current assets on the Consolidated Balance Sheets based on the Company’s intent and ability to utilize these assets within its normal operating cycle. The Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Leases The Company follows the provisions of ASC 842, and records right-of-use (“ROU”) assets and lease obligations for its operating leases, which are initially recognized based on the discounted future lease payments over the term of the lease. If the rate implicit in the Company’s leases is not readily determinable, the Company’s applicable incremental borrowing rate is used in calculating the present value of the sum of the lease payments. The lease term is defined as the non-cancelable period of the lease plus any options to extend or terminate the lease when it is reasonably certain that the Company will exercise the option. The Company has elected not to recognize ROU asset and lease obligations for its short-term leases, which are defined as leases with an initial term of 12 months or less. On December 1, 2025, we entered a 15-month rental arrangement for our office and inventory space, at which time we paid for the lease in full with a single payment of $65,610. Because there were no future lease payments to be made, we recorded an ROU asset at lease commencement for the value of the prepayment of $65,610 and had no lease liability to record. Before December 1, 2025, the Company had a month-to-month rental agreement. The Company recorded rent expense of $26,244 and $8,610, during the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, the weighted average remaining lease term was 8 months. Net Income (Loss) per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. As of June 30, 2026 and 2025 there were dilutive securities of 420,000 for the conversion of Series A Convertible Preferred Stock. These potentially dilutive securities were not included in the calculation of diluted net loss per common share on June 30, 2026 because they were antidilutive, therefore as of June 30, 2026, basic and diluted weighted average common shares outstanding and net loss per common share are the same. Recent Accounting Pronouncements The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements and has determined that there have been no standards that had, or will have, a material impact on its consolidated financial statements with exception to the following: In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires incremental disclosures about specific expense categories, including but not limited to, purchases of inventory, employee compensation, depreciation, amortization and selling expenses. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted and the amendments may be applied either prospectively or retrospectively. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability. U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 1: </td><td style="width:454.5pt" valign="top">Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. </td></tr> <tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top"> </td><td style="width:454.5pt" valign="top"> </td></tr> <tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 2: </td><td style="width:454.5pt" valign="top">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: </td></tr> </table> <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">quoted prices for similar assets or liabilities in active markets; </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">quoted prices for identical or similar assets or liabilities in markets that are not active; </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">inputs other than quoted prices that are observable for the asset or liability; and </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">inputs that are derived principally from or corroborated by observable market data by correlation or other means. </td></tr> </table> <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 3: </td><td style="width:454.5pt" valign="top">Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). </td></tr> </table> Our financial instruments consist of cash, accounts receivable and accounts payable, and note payable. We have determined that the book value of our outstanding financial instruments as of June 30, 2026, and December 31, 2025, approximates the fair value due to their short-term nature or interest rates that approximate prevailing market rates. Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of June 30, 2026: <table style="border-collapse:collapse;width:96.66%;margin-left:18pt"><tr><td style="width:37.94%" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 1 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 2 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 3 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Total </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%;padding-bottom:1pt" valign="bottom">Operating digital assets (see Note 6) </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Assets </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Liabilities </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) and with the rules and regulations of the Securities and Exchange Commission, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with US GAAP, have been condensed or omitted from these statements and should be read in conjunction with our audited financial statements. The financial statements are presented in US dollars, and the Company has adopted a December 31 year end.

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses. Actual results could differ from those estimates.

Segment Reporting The Company operates as a single operating and reportable segment as a retailer selling mental health and general wellness products. Our Chief Executive Officer, who serves as our Chief Operating Decision Maker (“CODM”), evaluates the Company’s financial performance and makes resource allocation decisions considering our one geographical area and on a consolidated basis. Accordingly, the CODM considers the revenue, operating expenses, and other income (expenses) of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these condensed consolidated financial statements that are regularly provided to the CODM.

Cash and Cash Equivalents Cash and cash equivalents include cash on hand, cash in banks and any highly liquid investments with a maturity of three months or less to the extent the funds are not being held for investment purposes. As of June 30, 2026 and December 31, 2025, the Company had no cash equivalents. The Company maintains four accounts at Wells Fargo Bank. Accounts at this institution are insured by the Federal Deposit Insurance Corporation up to $250,000. As of June 30, 2026 the Company has balances of $250,153 more than this limit.

250000

250153

Accounts Receivable and Allowance for Doubtful Accounts The Company reviews accounts receivable periodically for collectability and establishes an allowance for doubtful accounts and records bad debt expense when deemed necessary. The Company records an allowance for doubtful accounts that is based on historical trends, customer knowledge, any known disputes, and considers the aging of the accounts receivable balances combined with management’s estimate of future potential recoverability. Accounts and receivables are written off against the allowance after all attempts to collect a receivable have failed. As of June 30, 2026 and December 31, 2025, the allowance for doubtful accounts was $0.

Inventory The Company’s inventory is recognized in accordance with Accounting Standards Codification (“ASC”) 303. The Company uses the lower of cost (determined using the first-in, first-out method) or net realizable value for valuing inventories. As of June 30, 2026 and December 31, 2025, the Company had $333,779 and $336,348 of finished goods on hand, respectively. And on June 30, 2026 and December 31, 2025, the Company had $463,405 and $0 of raw materials on hand respectively.

333779

336348

463405

Income Taxes The provision for income taxes and deferred income taxes are determined using the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the financial carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. On a periodic basis, the Company assesses the probability that its net deferred tax assets, if any, will be recovered. If after evaluating all of the positive and negative evidence, a conclusion is made that it is more likely than not that some portion or all of the net deferred tax assets will not be recovered, a valuation allowance is provided by a charge to tax expense to reserve the portion of the deferred tax assets which are not expected to be realized.

Revenue Recognition The Company’s revenue is recognized in accordance with Accounting Standards Codification 606 and the Company sells products in the immune health supplement market. The Company’s performance obligation is to deliver product to customers therefore revenue is recognized once delivery occurs. Customers that are end users of the Company’s products will generally remit payment at the time of order placement, therefore payment received by the Company prior to product delivery is recorded as deferred revenue. Customers that are resellers of the Company’s products are offered credit terms and generally pay within 30-60 days. As of June 30, 2026 and December 31, 2025 deferred revenue was $2,550 and $136,590, respectively. Shipping and handling costs that occur are paid by the customer and is not recorded as revenue. The Company has a policy to provide a refund on any product returned by the customer and refunds are recorded as a reduction in revenue. Refunds have been minimal to date.

2550

136590

Advertising Costs Advertising costs are expensed as incurred. During the six months ended June 30, 2026 and 2025, the Company incurred advertising costs of $298,503 and $159,743, respectively.

298503

159743

Research and Development The Company charges research and development costs to expense when incurred. During the six months ended June 30, 2026 and 2025, the Company incurred $120,306 and $46,783 in research and development expenses, respectively.

120306

46783

Intangible Assets The Company accounts for its intangible assets in accordance with ASC 350. Costs incurred to renew or extend the term of intangible assets are expensed as incurred. As of June 30, 2026, the Company incurred $109,845 to file certain patent applications that showcase the Company’s innovative approach to health and wellness solutions. The patent costs were capitalized and will be amortized on a straight-line basis over its estimated useful life once the patents are granted. During the six months ended June 30, 2026 and June 30, 2025 no amortization expense was recorded as the patents were still pending. Amortization expense of $5,492 is expected for each year ended December 31, 2027 and beyond. We have several patent applications pending in the U.S. and internationally for our innovative methylithioninium (methylene blue) and mitochondrial health compositions: Patent Pending Product Overview and Update U.S. Non-Provisional Patent Application No. 18/931,277 for METHYLTHIONINIUM SALT-CONTAINING COMPOSITIONS AND METHODS, filed on 10/30/2024 International Patent Application No. PCT/US24/53487 for METHYLTHIONINIUM SALT-CONTAINING COMPOSITIONS AND METHODS, filed on 10/30/2024 U.S. Non-Provisional Patent Application No. 18/931,346 for COMPOSITIONS AND METHOD FOR SUPPORTING MITOCHONDRIAL, file on 10/30/2024 International Patent Application No. PCT/US24/53490 for COMPOSITIONS AND METHOD FOR SUPPORTING MITOCHONDRIAL, file on 10/30/2024. Filed on 10/30/2024 U.S. Provisional Patent Application No. 19/371,824 for TREATMENTS USING METHYLTHIONINIUM SALT, LIQUID MINERAL BLENDS, and/or SECONDARY PHYSIOLOGICALLY ACTIVE COMPOUND AND PHYSIOLOGICAL THERAPY, filed on 10/28/2025 U.S. Provisional Patent Application No. 63/712,895 for TREATMENTS USING METHYLTHIONINIUM SALT, SECONDARY PHYSIOLOGICALLY ACTIVE COMPOUND AND PHYSIOLOGICAL THERAPY, filed on 10/28/2024 U.S. Provisional Patent Application No. 63/754,434 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 2/5/2025 U.S. Provisional Patent Application No. 19/173,875 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 4/9/2025 International Patent Application No. PCT/US26/13809 for NUTRITIONAL SUPPLEMENT COMPOSITIONS AND METHODS FOR ENHANCING BIOLOGICAL FUNCTIONS, filed on 2/4/2026 U.S. Provisional Patent Application No. 64/025,742 for AQUEOUS PEPTIDE DELIVERY COMPOSITIONS AND METHODS, filed on 4/2/2026 All provisional applications were filed with the U.S. Patent and Trademark Office by Thorpe North and Western. We believe these filings cover multiple potential patents and product opportunities. Leadership is actively exploring partnerships and strategic alliances to maximize value for stakeholders. All products and methods described remain patent pending as of the date of this filing.

109845

Impairment of Long-lived Assets The Company applies the provisions of ASC 360, where applicable, to all long-lived assets and periodically evaluates the carrying value of long-lived assets to be held and used for impairment. Impairment losses are recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal. When long-lived assets are sold or retired, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations. During the six months ended June 30, 2026 and 2025, the Company recorded no impairment expense for their long-lived assets.

Digital Assets Held for Operational Purposes The Company holds certain digital assets (primarily USDT) exclusively as a medium of exchange to facilitate inventory procurement from international vendors. Digital assets held for operational purposes are classified as current assets on the Consolidated Balance Sheets based on the Company’s intent and ability to utilize these assets within its normal operating cycle. The Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting.

Leases The Company follows the provisions of ASC 842, and records right-of-use (“ROU”) assets and lease obligations for its operating leases, which are initially recognized based on the discounted future lease payments over the term of the lease. If the rate implicit in the Company’s leases is not readily determinable, the Company’s applicable incremental borrowing rate is used in calculating the present value of the sum of the lease payments. The lease term is defined as the non-cancelable period of the lease plus any options to extend or terminate the lease when it is reasonably certain that the Company will exercise the option. The Company has elected not to recognize ROU asset and lease obligations for its short-term leases, which are defined as leases with an initial term of 12 months or less. On December 1, 2025, we entered a 15-month rental arrangement for our office and inventory space, at which time we paid for the lease in full with a single payment of $65,610. Because there were no future lease payments to be made, we recorded an ROU asset at lease commencement for the value of the prepayment of $65,610 and had no lease liability to record. Before December 1, 2025, the Company had a month-to-month rental agreement. The Company recorded rent expense of $26,244 and $8,610, during the six months ended June 30, 2026 and 2025, respectively. As of June 30, 2026, the weighted average remaining lease term was 8 months.

65610

26244

8610

P8Y

Net Income (Loss) per Common Share Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. As of June 30, 2026 and 2025 there were dilutive securities of 420,000 for the conversion of Series A Convertible Preferred Stock. These potentially dilutive securities were not included in the calculation of diluted net loss per common share on June 30, 2026 because they were antidilutive, therefore as of June 30, 2026, basic and diluted weighted average common shares outstanding and net loss per common share are the same.

420000

Recent Accounting Pronouncements The Company has reviewed all the recent accounting pronouncements issued to date of the issuance of these financial statements and has determined that there have been no standards that had, or will have, a material impact on its consolidated financial statements with exception to the following: In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires incremental disclosures about specific expense categories, including but not limited to, purchases of inventory, employee compensation, depreciation, amortization and selling expenses. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted and the amendments may be applied either prospectively or retrospectively. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures. The amendments only impact disclosures and are not expected to have an impact on the Company’s financial condition and results of operations.

Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability. U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows: <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 1: </td><td style="width:454.5pt" valign="top">Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access. </td></tr> <tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top"> </td><td style="width:454.5pt" valign="top"> </td></tr> <tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 2: </td><td style="width:454.5pt" valign="top">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including: </td></tr> </table> <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">quoted prices for similar assets or liabilities in active markets; </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">quoted prices for identical or similar assets or liabilities in markets that are not active; </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">inputs other than quoted prices that are observable for the asset or liability; and </td></tr> <tr><td style="width:72pt" valign="top"> </td><td style="width:18pt" valign="top">- </td><td style="width:436.5pt" valign="top">inputs that are derived principally from or corroborated by observable market data by correlation or other means. </td></tr> </table> <table style="border-collapse:collapse;width:97.5%;margin-left:18pt"><tr><td style="width:18pt" valign="top"> </td><td style="width:54pt" valign="top">Level 3: </td><td style="width:454.5pt" valign="top">Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows). </td></tr> </table> Our financial instruments consist of cash, accounts receivable and accounts payable, and note payable. We have determined that the book value of our outstanding financial instruments as of June 30, 2026, and December 31, 2025, approximates the fair value due to their short-term nature or interest rates that approximate prevailing market rates. Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of June 30, 2026: <table style="border-collapse:collapse;width:96.66%;margin-left:18pt"><tr><td style="width:37.94%" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 1 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 2 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 3 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Total </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%;padding-bottom:1pt" valign="bottom">Operating digital assets (see Note 6) </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Assets </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Liabilities </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

<table style="border-collapse:collapse;width:96.66%;margin-left:18pt"><tr><td style="width:37.94%" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 1 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 2 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Level 3 </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td colspan="2" style="width:11.38%;border-bottom:1pt solid #000000" valign="bottom">Total </td><td style="width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%;padding-bottom:1pt" valign="bottom">Operating digital assets (see Note 6) </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:10.34%;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.04%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Assets </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:37.94%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:3.1%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:10.34%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:1.04%" valign="bottom"> </td></tr> <tr><td style="background-color:#FFFFFF;width:37.94%;padding-bottom:2.5pt" valign="bottom">Total Liabilities </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:3.1%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#FFFFFF;width:1.04%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#FFFFFF;width:10.34%;border-bottom:3px double #000000" valign="bottom">- </td><td style="background-color:#FFFFFF;width:1.04%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

4500 4500

4500

Note 4 - Related Party Transactions During the six months ended June 30, 2025 the Company purchased $1,153,197 worth of inventory from Ageless Holdings, LLC (“Holdings”), entity owned and controlled by the Company’s members of management and board of directors and paid $25,000 for services. Additionally, the Company received $1,391,635 worth of advances from Holdings to pay for operating expenses and the Company paid back $1,322,000 of the advances. During the six months ended June 30, 2026 the Company purchased $745,060 worth of inventory from Holdings, received $3,060 worth of advances from Holdings to pay for operating expenses, and paid back $150,000 of the advances. Additionally, during the first quarter of 2026 the Board of Directors decided to finalize a settlement agreement with Holdings and entered a promissory note on March 28, 2026 for $460,402, which was equal to the amount owed to them as of that date. The note carries an interest rate of 7% per annum, can be prepaid at any time without penalty, and matures on December 31, 2026. During the six months ended June 30, 2025, repayments of $200,000 were made toward this note payable.

1153197

25000

1391635

1322000

745060

3060

150000

460402

0.07

200000

Note 5 - Equity Common Stock The Company has 250,000,000, $0.0001 par value shares of voting common stock authorized. During the six months ended June 30, 2026, the Company issued 773,271 shares in common stock for cash proceeds of $773,271. On September 10, 2025, the Company filed a change in the articles of incorporation and increased the voting common stock from 75,000,000 to 250,000,000. In addition, the Company completed a 1 for 4 reverse common stock split, decreasing the number of voting common stock outstanding from 43,916,221 to 10,979,058. All share numbers presented in these consolidated financial statements have been retroactively adjusted for the stock split. During the six months ended June 30, 2025, there were no issuances of common stock. As of June 30, 2026 and December 31, 2025, the Company had 11,752,329 and 10,979,058 shares of common stock issued and outstanding, respectively. Preferred Stock On October 19, 2021, the Company filed a Certificate of Amendment to its Articles of Incorporation authorizing up to 5,000,000 shares of Preferred Stock, par value $0.0001 per share, with such rights, preferences and limitations as may be set forth in resolutions adopted by the Board of Directors. On November 1, 2021, the Company filed a Certificate of Designation designating 1,000,000 shares of Preferred Stock as Series A Convertible Preferred Stock (the “Series A”). Each share of the Series A is convertible into three shares of the Company’s common stock at the holder’s election, subject to a 4.99% beneficial ownership limitation which may be increased to 9.99% upon 61 days’ notice. During the six months ended June 30, 2026 and 2025 there were no issuances of preferred stock. As of June 30, 2026 and December 31, 2025, the Company had 140,000 shares of Series A Convertible Preferred Stock outstanding.

250000000

0.0001

773271

75000000

250000000

Company completed a 1 for 4 reverse common stock split

43916221

10979058

11752329

10979058

5000000

0.0001

1000000

Each share of the Series A is convertible into three shares of the Company’s common stock at the holder’s election, subject to a 4.99% beneficial ownership limitation which may be increased to 9.99% upon 61 days’ notice.

140000

Note 6 – Digital Assets The Company accounts for digital assets in accordance with ASU 2023-08, which requires entities to measure crypto assets at fair value with changes recognized in the Statement of Operations each reporting period. The following table presents the Company’s Digital Asset holdings as of June 30, 2026: <table style="border-collapse:collapse;width:94.28%;margin-left:18pt"><tr style="height:14.3pt"><td style="padding-bottom:1pt" valign="bottom"> </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="border-bottom:1pt solid #000000" valign="bottom">Quantity </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="border-bottom:1pt solid #000000" valign="bottom">Cost Basis </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="width:15.22%;border-bottom:1pt solid #000000" valign="bottom">Fair Value </td></tr> <tr style="height:14.3pt"><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom">USDT </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr style="height:14.3pt"><td style="padding-bottom:2.5pt" valign="bottom">Total digital assets held as of June 30, 2026 </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="border-bottom:3px double #000000" valign="bottom">$ </td><td style="border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="border-bottom:3px double #000000" valign="bottom">$ </td><td style="border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="width:1%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table> The following table presents a roll-forward of total digital assets for the six months ended June 30, 2026, based on the fair value model under ASU 2023-08: <table style="border-collapse:collapse;width:84.16%;margin-left:36pt"><tr><td style="width:78.22%" valign="bottom"> </td><td style="width:1.96%;padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="width:19.82%;border-bottom:1pt solid #000000" valign="bottom">Fair Value </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%" valign="bottom">Balance as of December 31, 2025 </td><td style="background-color:#CCEEFF;width:1.96%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:14.86%" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.98%" valign="bottom"> </td></tr> <tr><td style="width:78.22%" valign="bottom">Purchase of digital assets </td><td style="width:1.96%" valign="bottom"> </td><td style="width:2.98%" valign="bottom"> </td><td style="width:14.86%" valign="bottom">8,519 </td><td style="width:1.98%" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%" valign="bottom">Operating expenses paid with digital assets </td><td style="background-color:#CCEEFF;width:1.96%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:14.86%" valign="bottom">(4) </td><td style="background-color:#CCEEFF;width:1.98%" valign="bottom"> </td></tr> <tr><td style="width:78.22%;padding-bottom:1pt" valign="bottom">Purchase of inventory with digital assets </td><td style="width:1.96%;padding-bottom:1pt" valign="bottom"> </td><td style="width:2.98%;border-bottom:1pt solid #000000" valign="bottom"> </td><td style="width:14.86%;border-bottom:1pt solid #000000" valign="bottom">(4,015) </td><td style="width:1.98%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%;padding-bottom:2.5pt" valign="bottom">Balance as of June 30, 2026 </td><td style="background-color:#CCEEFF;width:1.96%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:14.86%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.98%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

<table style="border-collapse:collapse;width:94.28%;margin-left:18pt"><tr style="height:14.3pt"><td style="padding-bottom:1pt" valign="bottom"> </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="border-bottom:1pt solid #000000" valign="bottom">Quantity </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="border-bottom:1pt solid #000000" valign="bottom">Cost Basis </td><td style="padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="width:15.22%;border-bottom:1pt solid #000000" valign="bottom">Fair Value </td></tr> <tr style="height:14.3pt"><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom">USDT </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;padding-bottom:1pt" valign="bottom"> </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;border-bottom:1pt solid #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr style="height:14.3pt"><td style="padding-bottom:2.5pt" valign="bottom">Total digital assets held as of June 30, 2026 </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="border-bottom:3px double #000000" valign="bottom">$ </td><td style="border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="padding-bottom:2.5pt" valign="bottom"> </td><td style="border-bottom:3px double #000000" valign="bottom">$ </td><td style="border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="width:1%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

4500

<table style="border-collapse:collapse;width:84.16%;margin-left:36pt"><tr><td style="width:78.22%" valign="bottom"> </td><td style="width:1.96%;padding-bottom:1pt" valign="bottom"> </td><td colspan="3" style="width:19.82%;border-bottom:1pt solid #000000" valign="bottom">Fair Value </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%" valign="bottom">Balance as of December 31, 2025 </td><td style="background-color:#CCEEFF;width:1.96%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:14.86%" valign="bottom">- </td><td style="background-color:#CCEEFF;width:1.98%" valign="bottom"> </td></tr> <tr><td style="width:78.22%" valign="bottom">Purchase of digital assets </td><td style="width:1.96%" valign="bottom"> </td><td style="width:2.98%" valign="bottom"> </td><td style="width:14.86%" valign="bottom">8,519 </td><td style="width:1.98%" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%" valign="bottom">Operating expenses paid with digital assets </td><td style="background-color:#CCEEFF;width:1.96%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%" valign="bottom"> </td><td style="background-color:#CCEEFF;width:14.86%" valign="bottom">(4) </td><td style="background-color:#CCEEFF;width:1.98%" valign="bottom"> </td></tr> <tr><td style="width:78.22%;padding-bottom:1pt" valign="bottom">Purchase of inventory with digital assets </td><td style="width:1.96%;padding-bottom:1pt" valign="bottom"> </td><td style="width:2.98%;border-bottom:1pt solid #000000" valign="bottom"> </td><td style="width:14.86%;border-bottom:1pt solid #000000" valign="bottom">(4,015) </td><td style="width:1.98%;padding-bottom:1pt" valign="bottom"> </td></tr> <tr><td style="background-color:#CCEEFF;width:78.22%;padding-bottom:2.5pt" valign="bottom">Balance as of June 30, 2026 </td><td style="background-color:#CCEEFF;width:1.96%;padding-bottom:2.5pt" valign="bottom"> </td><td style="background-color:#CCEEFF;width:2.98%;border-bottom:3px double #000000" valign="bottom">$ </td><td style="background-color:#CCEEFF;width:14.86%;border-bottom:3px double #000000" valign="bottom">4,500 </td><td style="background-color:#CCEEFF;width:1.98%;padding-bottom:2.5pt" valign="bottom"> </td></tr> </table>

-8519

4 4015

4500

Note 7 - Subsequent Events The Company has evaluated all events that occur after the balance sheet date through August 7, 2026, the date when the financial statements were available to be issued, to determine if they must be reported. Management of the Company determined that there are no material subsequent events to be disclosed.